84 results
8-K
EX-99.1
BRSF
Brain Scientific Inc.
18 Oct 21
Regulation FD Disclosure
1:17pm
solutions OUR MOTION PRODUCTS 8
Typical DC Technology $140 Limited precision Complex control Heavy materials Many parts Typical Conventional Piezo $1,200 … High precision Sophisticated controls Heavy materials Complex parts Our Innovative MOTION TECHNOLOGY $120 Precise Simple to control Lightweight
8-K
EX-99.1
BRSF
Brain Scientific Inc.
20 Oct 20
Brain Scientific Appoints Stuart Bernstein as VP of Marketing
7:52am
disposable EEG headset with 22 electrodes and 19 active EEG channels. The new device uses velcro materials for better adhesion during EEG testing … , lack of product diversification, volatility in the price of the Company’s raw materials and the Company’s failure to implement the Company’s business
8-K
EX-99.1
BRSF
Brain Scientific Inc.
13 Jan 22
Regulation FD Disclosure
5:28pm
issues OUR MOTION PRODUCTS 8
DC Technology $140 Limited precision Complex control Heavy materials Many parts High precision Sophisticated controls Heavy … materials Complex parts Conventional Piezo $1,200 Our Innovative MOTION TECHNOLOGY $120 Precise Simple to control Lightweight materials Few parts
8-K
BRSF
Brain Scientific Inc.
16 Nov 18
Regulation FD Disclosure
2:07pm
Item 7.01 Regulation FD Disclosure.
Brain Scientific Inc. (the “Company”) is furnishing presentation materials included as Exhibit 99.1 … in the following Exhibit Index is furnished as part of this Form 8-K:
Exhibit No.
Document
Presentation Materials
SIGNATURES
Pursuant to the requirements
8-K
BRSF
Brain Scientific Inc.
15 Nov 19
Entry into a Material Definitive Agreement
4:31pm
or practices.
Item 7.01
Regulation FD Disclosure
The Company is furnishing presentation materials included as Exhibit 99.1 to this current report … Materials
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
D
g3yanlu
29 Dec 15
$10K in equity
12:00am
8-K
EX-10.1
kwo15lv
11 Feb 19
Entry into a Material Definitive Agreement
1:51pm
D
2oc8dkyn
25 Feb 19
$500K in options / securities to be acquired, sold $230K, 2 investors
12:20pm
D
rpyibwrxosf5q3n6cdm
9 Oct 18
Indefinite amount in equity, 43 investors
11:48am
D
w4i1pakgmiybvs
13 Jan 22
$20M in debt / options, sold $9.66M, 13 investors
4:33pm
D
xbeg4tawq6
19 Jul 22
$5.15M in debt / options, sold $5.15M, 11 investors
12:59pm
8-K
EX-99.1
i0vv70flgudkj 88b8
3 Aug 20
Brain Scientific Commences Trading on The OTCQB® Venture Market
7:38am
8-K
EX-10.1
56rtoro
25 Oct 19
Entry into a Material Definitive Agreement
12:00am
8-K
a1pmonveidce 0kw6wx
13 Jan 22
Regulation FD Disclosure
5:28pm
8-K
EX-99.1
ld8uml
17 Aug 20
Brain Scientific's Expansion Relocates Its Headquarters to Bohemia, New York
11:47am
8-K
EX-10.1
bqiramg8y3mtmrrtdx
31 Dec 20
Entry into a Material Definitive Agreement
4:04pm
8-K
EX-99.1
qwkc3m
2 Nov 22
Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer
5:56pm
8-K
EX-99.1
tr4gtn f96
3 Nov 20
Brain Scientific Announces New VP of Strategy and Business Development
7:39am